重症医学科SCI选刊-2023丨发文最多的期刊,及审稿周期大全
导言:
(2023) Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptations ERJ open research
(2023) Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials JAMA
(2023) Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial The Lancet. Respiratory medicine
(2023) Home monitoring in interstitial lung diseases The Lancet. Respiratory medicine
(2023) Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease Rheumatology (Oxford, England)
微信扫码关注该文公众号作者